Company / R&D per Share
LeMaitre Vascular R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.63
FY2025
5-year range
$0.46 / $0.79
FY2021-FY2025
Trend
-11.2%
vs FY2024
Sector context
#85 of 108
Health Care
What the data says
LeMaitre Vascular's r&d per share of $0.63 is lower than 79% of companies in the Health Care sector (FY2025). Declined from $0.79 to $0.63 over the past 2 years.
Based on SEC 10-K filings.
0.63 in FY2025 with a 5-year CAGR of +9.1%.
Declined from $0.79 to $0.63 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +8.3%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 108This company $0.63 Sector average $2.07
▼
-69.8% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 11.2% year-over-year.
- Ranks #85 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | -11.2% |
| FY2024 | $0.71 | -10.7% |
| FY2023 | $0.79 | +60.2% |
| FY2022 | $0.49 | +8.1% |
| FY2021 | $0.46 | +12.7% |
| FY2020 | $0.40 | +22.2% |
| FY2019 | $0.33 | +3.8% |
| FY2018 | $0.32 | +6.7% |
| FY2017 | $0.30 | -17.2% |
| FY2016 | $0.36 | +8.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026